The prevalence of thyroid disease in patients with vitiligo: a systematic review. - Wikidata - awgldk - TriplyDB

The prevalence of thyroid disease in patients with vitiligo: a systematic review.

The prevalence of thyroid disease in patients with vitiligo: a systematic review.

http://www.wikidata.org/entity/Q38031886

about

Vitiligo--part 1 Evaluation of the serum zinc level in patients with vitiligo.Transporter TAP1-637G and immunoproteasome PSMB9-60H variants influence the risk of developing vitiligo in the Saudi population Anti-thyroid peroxidase antibody in vitiligo: a prevalence study.A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations.The Frequency of Autoimmune Thyroid Disease in Alopecia Areata and Vitiligo Patients.Adult Onset Vitiligo: Multivariate Analysis Suggests the Need for a Thyroid Screening.Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.Oxidative stress and immune system in vitiligo and thyroid diseases.Vitiligo: An Update on Pathophysiology and Treatment Options.Construction of a Comprehensive Protein-Protein Interaction Map for Vitiligo Disease to Identify Key Regulatory Elements: A Systemic Approach.Evaluation of autoimmune thyroid disease in melasma.The role of the Th1 chemokine CXCL10 in vitiligo.Correlation of Serum Thyroid Hormones Autoantibodies with Self-Reported Exposure to Thyroid Disruptors in a Group of Nonsegmental Vitiligo Patients.Comparison of Autoimmune Thyroid Disease in Patients With Progressive and Stable Vitiligo.Vitiligo and alopecia areata: apples and oranges?Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years.Vitiligo and Autoimmune Thyroid Disorders.Commentary from the Editorial Board to Vitiligo: interplay between oxidative stress and immune system (Laddha et al.).Factors Associated with Development of Vitiligo in Patients with Halo Nevus.Prevalence of Thyroid Abnormalities in Thai Patients with Vitiligo.Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.Leukoderma in patients with atopic dermatitis.Alopecia areata and vitiligo - partners in crime or a case of false alibis.Vitiligo

P2860

Q27028001-C1FD1275-CE2D-40A0-8056-B38023035969 Q33645847-3D85E397-C0F3-47B4-AFA8-B0AACE5A9724 Q34753937-AFA423B6-E3AD-4010-9798-B325DADE858B Q35012290-F28E3668-3F0F-406F-AEEA-FF1E38FBB62E Q35578224-2E77E47D-8EAA-4597-9B09-A0D01E8D0930 Q36013154-C4C50A16-C234-48B0-AF75-7C78B651BD70 Q37322584-836FBD38-0E6B-49F2-8D87-455C0AD46339 Q37611016-4C821BBB-A39A-466E-888A-4DD69E8F9AFD Q38403600-67C585B0-0FAF-407C-A8C7-94E7489EDAA7 Q38675361-1108210D-385C-4EB3-A245-C803CC0C451B Q38909947-E714BB45-5D55-4F23-A511-7BFEE9FDDD9D Q39025117-18B2229A-462E-4E1E-812C-4AA028FE69D3 Q40858470-19B92E10-5A1E-4094-A8D7-0C1472792D07 Q41380048-61A79852-50EC-4C1F-91C4-1DE932AFF9C2 Q41441823-D7A56E3B-C8BF-45BD-AB52-BBF8C5CB265F Q41855663-58C89DEF-0755-4BAA-9BD6-967B609D3FDC Q45153427-BEFD43D2-B9BF-46BC-B885-96F8690A7DC1 Q46256690-76120A69-180F-4B4A-91E0-15DA3BEABF66 Q46851464-BF1F882C-975C-4F08-9330-2F8BC9E049ED Q47218642-F2A4FA8D-4C2E-49BC-93A9-815389B73361 Q47549740-4A456293-8BA6-4A86-BAA4-C81141535819 Q48152140-F75F325C-8CA0-44B9-84F9-E845CA779797 Q51066708-A62A1F86-7900-460C-8398-24A012E790A8 Q51763140-A23D1FD7-D16C-4AA4-9A83-615E077A3F98 Q56996499-509C9A3F-ADD6-4F5E-A281-0A63B35B49D6

P2860

The prevalence of thyroid disease in patients with vitiligo: a systematic review.

http://www.wikidata.org/entity/Q38031886

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The prevalence of thyroid disease in patients with vitiligo: a systematic review.

@en

type

label

The prevalence of thyroid disease in patients with vitiligo: a systematic review.

@en

prefLabel

The prevalence of thyroid disease in patients with vitiligo: a systematic review.

@en

P1433

Q38031886-3D34FA20-C107-47D0-BF21-022F74DAE463

P1476

Q38031886-DDCB916F-A5CB-468B-A172-E1C3ECD3A850

P2093

Q38031886-0A3D32C9-3212-4617-AF01-3F4BB70BF85E

Q38031886-12901CC8-3290-49DE-8039-B6286BC45A8A

Q38031886-36A0D117-E913-408F-9B00-F2A05AEECA12

Q38031886-67C7A1D5-E377-43F6-A9DC-B2D297207C65

Q38031886-75E5B41B-1FD8-436D-B9BE-A7CDF8FDB516

Q38031886-DBBD2F80-B0E6-455A-8AD9-4440D8AA227B

Q38031886-E9DBE005-E1A9-4F89-A840-920919871D21

P2860

Q38031886-0065E1EC-D0CC-487A-8DC0-EDFEC71C5526

Q38031886-06F5866B-AF90-4A51-BE3A-3DFCD73142F6

Q38031886-0EFFDECD-B2C8-4819-A10A-81CF65322ED3

Q38031886-1682D2B9-7B2D-4CED-BAAC-ABF0AB29989B

Q38031886-203E6072-4BCF-4892-86AC-2640BD8CA537

Q38031886-20F72CB5-FF23-4ADB-8716-F6D85CE09C0C

Q38031886-279125D8-4C2C-41F7-A93A-F47F68603D64

Q38031886-3057B62C-08CB-45C8-AA56-472AB9E0AA18

Q38031886-3430D60E-9580-4B2D-A952-36EEE234E1A2

Q38031886-3ADA1E31-B4E8-40A9-A8A1-2187ED5CDE0C

P304

Q38031886-A6F42C99-31B0-475F-85DF-CD44671088AF

P31

Q38031886-1529EB41-BDE8-472F-839A-7279BA14763C

P356

Q38031886-D41EBD19-7161-4855-AD9E-72F621AAC204

P407

Q38031886-3010A9AC-33EA-49AB-B377-FFB9FE163FE2

P433

Q38031886-35599B40-4845-4812-ACF6-473B92A9663C

P478

Q38031886-7DF4326D-3078-4A08-AD26-23ADC110F655

P50

Q38031886-15D53BD7-731A-46B3-8411-2DCE66CF1AF3

P577

Q38031886-4075743B-B00D-4D09-AE15-759E5A3F65EE

P698

Q38031886-434AE654-C1E8-4212-AB3F-FF51FD48CE67

P356

J.1365-2133.2012.11198.X

P1433

British Journal of Dermatology

P1476

The prevalence of thyroid disease in patients with vitiligo: a systematic review.

@en

P2093

A Wolkerstorfer

http://www.w3.org/2001/XMLSchema#string

C Vrijman

http://www.w3.org/2001/XMLSchema#string

J P W van der Veen

http://www.w3.org/2001/XMLSchema#string

M M G Leeflang

http://www.w3.org/2001/XMLSchema#string

M W Kroon

http://www.w3.org/2001/XMLSchema#string

P I Spuls

http://www.w3.org/2001/XMLSchema#string

R M Luiten

http://www.w3.org/2001/XMLSchema#string

P2860

Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo

Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism

Anti-thyroid peroxidase antibody and vitiligo: a controlled study

Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

Common variants in FOXP1 are associated with generalized vitiligo.

Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo.

Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

New insights in segmental vitiligo: case report and review of theories.

Autoantibodies as predictors of disease.

An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits.

P304

1224-1235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2133.2012.11198.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P50

Jacqueline Limpens

P577

2012-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22860695

http://www.w3.org/2001/XMLSchema#string